SHILPAMED — Shilpa Medicare Balance Sheet
0.000.00%
- IN₹184.31bn
- IN₹189.99bn
- IN₹15.39bn
Annual balance sheet for Shilpa Medicare, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | R2023 March 31st | C2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 338 | 213 | 302 | 260 | 413 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 4,637 | 3,947 | 4,686 | 5,676 | 6,676 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 8,872 | 7,696 | 8,762 | 9,857 | 11,098 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 14,036 | 15,375 | 15,962 | 16,750 | 17,821 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 28,755 | 29,039 | 30,932 | 33,107 | 37,056 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 6,115 | 7,844 | 6,936 | 6,742 | 8,481 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 10,533 | 11,206 | 12,845 | 9,385 | 11,144 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 18,222 | 17,833 | 18,087 | 23,722 | 25,912 |
| Total Liabilities & Shareholders' Equity | 28,755 | 29,039 | 30,932 | 33,107 | 37,056 |
| Total Common Shares Outstanding |